92 related articles for article (PubMed ID: 31359385)
41. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.
Goufman EI; Moshkovskii SA; Tikhonova OV; Lokhov PG; Zgoda VG; Serebryakova MV; Toropygin IY; Vlasova MA; Safarova MR; Makarov OV; Archakov AI
Biochemistry (Mosc); 2006 Apr; 71(4):354-60. PubMed ID: 16615854
[TBL] [Abstract][Full Text] [Related]
42. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
43. Network generation enhances interpretation of proteomics data sets by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
Wang X; Zhang A; Sun H; Wu G; Sun W; Yan G
Analyst; 2012 Oct; 137(20):4703-11. PubMed ID: 22950079
[TBL] [Abstract][Full Text] [Related]
44. Comparative proteomics of ovarian epithelial tumors.
An HJ; Kim DS; Park YK; Kim SK; Choi YP; Kang S; Ding B; Cho NH
J Proteome Res; 2006 May; 5(5):1082-90. PubMed ID: 16674097
[TBL] [Abstract][Full Text] [Related]
45. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
46. Molecular proteomics imaging of tumor interfaces by mass spectrometry.
Kang S; Shim HS; Lee JS; Kim DS; Kim HY; Hong SH; Kim PS; Yoon JH; Cho NH
J Proteome Res; 2010 Feb; 9(2):1157-64. PubMed ID: 19821573
[TBL] [Abstract][Full Text] [Related]
47. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
Liu Z; Huang Z; Yang W; Li Z; Xing S; Li H; Hu B; Li P
Neoplasma; 2017; 64(1):32-39. PubMed ID: 27881002
[TBL] [Abstract][Full Text] [Related]
48. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
[TBL] [Abstract][Full Text] [Related]
50. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
51. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
[TBL] [Abstract][Full Text] [Related]
52. The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance.
Fernández LP; Sánchez-Martínez R; Vargas T; Herranz J; Martín-Hernández R; Mendiola M; Hardisson D; Reglero G; Feliu J; Redondo A; Ramírez de Molina A
Sci Rep; 2018 May; 8(1):8485. PubMed ID: 29855486
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
Fillet M; Cren-Olivé C; Renert AF; Piette J; Vandermoere F; Rolando Ch; Merville MP
J Proteome Res; 2005; 4(3):870-80. PubMed ID: 15952734
[TBL] [Abstract][Full Text] [Related]
54. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
[TBL] [Abstract][Full Text] [Related]
55. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
56. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
[TBL] [Abstract][Full Text] [Related]
57. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq.
Shih AJ; Menzin A; Whyte J; Lovecchio J; Liew A; Khalili H; Bhuiya T; Gregersen PK; Lee AT
PLoS One; 2018; 13(11):e0206785. PubMed ID: 30383866
[TBL] [Abstract][Full Text] [Related]
58. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
Dai Z; Yin J; He H; Li W; Hou C; Qian X; Mao N; Pan L
Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754
[TBL] [Abstract][Full Text] [Related]
59. The comparison of glycosphingolipids isolated from an epithelial ovarian cancer cell line and a nontumorigenic epithelial ovarian cell line using MALDI-MS and MALDI-MS/MS.
Rajanayake KK; Taylor WR; Isailovic D
Carbohydr Res; 2016 Aug; 431():6-14. PubMed ID: 27267063
[TBL] [Abstract][Full Text] [Related]
60. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
